Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose intravenous heparin for prevention of central venous catheter-related thrombosis in children in intensive care
ACTRN12611000070932Phase 3Recruiting
- Sponsor
- Women's and Children's Hospital
- Start
- Apr 2010
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in catheter-related thrombosis (CRT) comparing Low-dose intravenous heparin with Normal saline placebo (2 arms). Primary endpoint: Any thrombus in the catheterized vein. Started Apr 2010; status: recruiting.
02
Drugs
heparin
03
Conditions
catheter-related thrombosis (CRT)
Beyond the preview
Go deeper on ACTRN12611000070932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000070932.